Viejas drogas, nuevos fármacos

Luis Jiménez Treviño, Ángela Velasco, Julia Rodríguez-Revuelta, Pilar A. Sáiz

Resumen


Editorial del vol 32(1).

Palabras clave


Editorial; Drogas; Fármacos.

Texto completo:

PDF PDF (English)

Referencias


Berman R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S. y Krystal, J.H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47, 351-354. doi:10.1016/s0006-3223(99)00230-9.

Blasco-Fontecilla, H. (2018) Posmodernidad, sociedades adictivas, cannabis y comportamiento suicida: ¿Hacia un mundo feliz? Adicciones, 30, 3-8. doi:10.20882/adicciones.1104.

Canuso, C.M., Singh, J.B., Fedgchin, M., Alphs, L., Lane, R., Lim, P.,… Drevets, W.C. (2018). Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study. American Journal of Psychiatry, 175, 620-630. doi:10.1176/appi.ajp.2018.17060720. 

Cristea, I.A. y Naudet, F. (2019). US Food and Drug Administration approval of esketamine and brexanolone. Lancet Psychiatry. Avance de publicación on-line. doi:10.1016/S2215-0366(19)30292-5.

Goforth, H.W. y Holsinger, T. (2007). Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. The Journal of ECT, 23, 23-25. doi:10.1097/01.yct.0000263257.44539.23.

Gómez-Arnau, J. y Dolengevich, H. Ketamina. (2015). En H. Dolengevich (Ed.), Nuevas Drogas Psicoactivas. (pp. 229-241). Madrid: Entheos

Guardia Serecigni, J. (2018). Epidemia de sobredosis relacionada con la prescripción de analgésicos opioides en Estados Unidos. Adicciones, 30, 87-92. doi:10.20882/adicciones.936.

Han, Y., Chen, J., Zou, D., Zheng, P., Li, Q., Wang, H.,… Xie, P. (2016). Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies. Neuropsychiatric Disease and Treatment, 12, 2859-2867. doi:10.2147/NDT.S117146.

Hill, K.P., Palastro, M.D. y George, T.P. (2019).Therapeutic cannabis use in 2018: where do we stand? Lancet Psychiatry, 6, 88-89. doi:10.1016/S2215-0366(18)30417-6.

Mion, G. (2017). History of anaesthesia: The ketamine story - past, present and future. European Journal of Anaesthesiology, 34, 571-575. doi:10.1097/EJA.0000000000000638.

Okamoto, N., Nakai, T., Sakamoto, K., Nagafusa, Y., Higuchi, T. y Nishikawa, T. (2010). Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. The Journal of ECT, 26, 223-227. doi:10.1097/YCT.0b013e3181c3b0aa.

Slomski, A. (2019). Esketamine Nasal Spray Effective in Treatment-Resistant Depression. JAMA, 322, 296. doi:10.1001/jama.2019.10368.




DOI: https://doi.org/10.20882/adicciones.1474

Enlaces refback

  • No hay ningún enlace refback.